|
|
|
Insider
Information: |
Sherman Matthew L |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
197,506 |
|
Indirect Shares
|
8,500 |
|
|
Direct
Value |
$15,069,295 |
|
|
Indirect Value
|
$1,519,375 |
|
|
Total
Shares |
206,006 |
|
|
Total
Value |
$16,588,670 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
13
|
Stock
price went up :
|
0
|
8
|
Stock
price went down : |
0
|
5
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.6
|
Percentage
Gain/Loss : |
0.0%
|
377.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Acceleron Pharma Inc |
XLRN |
EVP & Chief Medical Of... |
2018-04-03 |
68,767 |
2018-04-03 |
8,500 |
Premium* |
|
Pulmatrix Inc |
PULM |
Director |
2018-04-03 |
20,000 |
2018-04-03 |
0 |
Premium* |
|
Deciphera Pharmaceuticals, Inc. |
DCPH |
|
2024-02-16 |
108,739 |
2019-10-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2015-01-20 |
4 |
AS |
$41.23 |
$233,210 |
D/D |
(5,600) |
24,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2015-01-20 |
4 |
OE |
$0.48 |
$10,048 |
D/D |
5,600 |
24,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-03-04 |
4 |
OE |
$0.48 |
$10,048 |
D/D |
5,600 |
21,604 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-03-04 |
4 |
AS |
$40.21 |
$227,999 |
D/D |
(5,600) |
20,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-03-04 |
4 |
AS |
$40.63 |
$57,223 |
I/I |
(1,400) |
17,700 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-03-18 |
4 |
OE |
$0.48 |
$5,984 |
D/D |
4,800 |
20,804 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-03-18 |
4 |
AS |
$41.07 |
$197,652 |
D/D |
(4,800) |
20,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-03-18 |
4 |
AS |
$41.13 |
$49,419 |
I/I |
(1,200) |
16,500 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-04-16 |
4 |
OE |
$3.88 |
$46,560 |
D/D |
12,000 |
32,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-04-20 |
4 |
AS |
$33.50 |
$33,500 |
I/I |
(1,000) |
15,500 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-04-20 |
4 |
AS |
$33.53 |
$134,120 |
D/D |
(4,000) |
32,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-04-20 |
4 |
OE |
$0.48 |
$1,920 |
D/D |
4,000 |
36,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-05-18 |
4 |
OE |
$0.48 |
$10,048 |
D/D |
5,600 |
37,604 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-05-18 |
4 |
AS |
$32.41 |
$181,496 |
D/D |
(5,600) |
32,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-05-18 |
4 |
AS |
$32.20 |
$45,080 |
I/I |
(1,400) |
14,100 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-06-18 |
4 |
AS |
$31.07 |
$43,998 |
I/I |
(1,400) |
12,700 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-06-18 |
4 |
AS |
$31.57 |
$176,792 |
D/D |
(5,600) |
32,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-06-18 |
4 |
OE |
$0.48 |
$10,048 |
D/D |
5,600 |
37,604 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-07-20 |
4 |
OE |
$0.48 |
$5,984 |
D/D |
4,800 |
32,804 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-07-20 |
4 |
AS |
$32.29 |
$155,781 |
D/D |
(4,800) |
32,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-07-20 |
4 |
AS |
$32.31 |
$38,954 |
I/I |
(1,200) |
11,500 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-08-18 |
4 |
OE |
$0.48 |
$10,048 |
D/D |
5,600 |
33,604 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-08-18 |
4 |
AS |
$30.83 |
$173,990 |
D/D |
(5,600) |
32,004 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-08-18 |
4 |
AS |
$30.99 |
$43,910 |
I/I |
(1,400) |
10,100 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
|
2015-08-24 |
4 |
OE |
$3.88 |
$77,600 |
D/D |
20,000 |
52,004 |
0 |
- |
|
122 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|